PillCinacalcet
Cinacalcet Hydrochloride
4 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it4 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | unknown | 9 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 4 | SUPPLYING |
| Exelan Pharmaceuticals, Inc. | unknown | 3 | SUPPLYING |
| Cipla USA Inc. | unknown | 3 | SUPPLYING |
| Dr.Reddy's laboratories Limited | unknown | 4 | EXITED 2026 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jun 29, 2026RECALLRecall (Class II): Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India…
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI). — Recalling firm: Cipla USA, Inc. — USA Nationwide
- Jun 29, 2026RECALLRecall (Class II): Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India…
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI). — Recalling firm: Cipla USA, Inc. — USA Nationwide
- Jun 29, 2026RECALLRecall (Class II): Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India…
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI). — Recalling firm: Cipla USA, Inc. — USA Nationwide
- Mar 16, 2026RECALLRecall (Class II): Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga,…
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit — Recalling firm: Cipla USA, Inc. — Nationwide in the USA
- Mar 16, 2026RECALLRecall (Class II): Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga,…
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit — Recalling firm: Cipla USA, Inc. — Nationwide in the USA
- Mar 16, 2026RECALLRecall (Class II): Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga,…
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit — Recalling firm: Cipla USA, Inc. — Nationwide in the USA
- Nov 14, 2025RECALLRecall (Class II): Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independ…
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits. — Recalling firm: Cipla USA, Inc. — Nationwide in the US
- Nov 14, 2025RECALLRecall (Class II): Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independ…
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits. — Recalling firm: Cipla USA, Inc. — Nationwide in the US
- Nov 14, 2025RECALLRecall (Class II): Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independ…
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits. — Recalling firm: Cipla USA, Inc. — Nationwide in the US
- Oct 9, 2024RECALLRecall (Class II): Cinacalcet Tablets, 30 mg, 30-count bottle, Rx Only, Dr. Reddy's Laboratories Inc, Princeton, NJ 08540, Made in India, …
CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit — Recalling firm: Dr. Reddy's Laboratories, Inc. — USA Nationwide.
- Oct 9, 2024RECALLRecall (Class II): Cinacalcet Tablets, 90 mg, 30-count bottle, Rx Only, Dr. Reddy's Laboratories Inc, Princeton, NJ 08540, Made in India.,…
CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit — Recalling firm: Dr. Reddy's Laboratories, Inc. — USA Nationwide.
- Oct 9, 2024RECALLRecall (Class II): Cinacalcet Tablets, 60 mg, 30-count bottles, Rx Only, Dr. Reddy's Laboratories Inc, Princeton, NJ 08540, Made in India,…
CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit — Recalling firm: Dr. Reddy's Laboratories, Inc. — USA Nationwide.